uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Conditions: Urothelial Carcinoma; Urothelial Carcinoma Recurrent; Urothelial Carcinoma Ureter; Urothelial Carcinoma Ureter Recurrent; Urothelial Cancer of Renal Pelvis; Urothelial Carcinoma of the Renal Pelvis and Ureter; Carcinoma, Transitional Cell; Transitional Cell C arcinoma of Renal Pelvis Intervention: Drug: Jelmyto (mitomycin) for pyelocalyceal solution Sponsor: UroGen Pharma Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials